Pure Global

Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME) - Trial NCT06380855

Access comprehensive clinical trial information for NCT06380855 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Recruiting. The study focuses on Rectal Cancer. Target enrollment is 5 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06380855
Recruiting
procedure
Trial Details
ClinicalTrials.gov • NCT06380855
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)

Study Focus

Rectal Cancer

Flexible colonoscope assisted hybrid transanal total mesorectal resection

Observational

procedure

Sponsor & Location

Sun Yat-sen University

Guangzhou, China

Timeline & Enrollment

N/A

Aug 24, 2022

Aug 24, 2025

5 participants

Primary Outcome

Success rate of operation

Summary

The investigators propose to use flexible endoscopy combined with transanal total mesorectal
 resection to further reduce anal injury.

ICD-10 Classifications

Malignant neoplasm of rectum
Carcinoma in situ: Rectum
Benign neoplasm: Rectum
Secondary malignant neoplasm of large intestine and rectum
Carcinoma in situ: Rectosigmoid junction

Data Source

ClinicalTrials.gov

NCT06380855

Non-Device Trial